ArticlePloS one2021

Correction: 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial.

PLOS ONE StaffPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.